September 2011 Vol 11 No 7 www.drug-dev.com
IN THIS
ISSUE
INTERVIEW WITH
MACUCLEAR’S
CEO
PHILIP RALSTON
Beyond The
Headlines 18
Derek Hennecke
Functional
Excipients 22
João Correia
António Bica
Patient
Compliance 30
Steven Hamlen, MBA
Karen MacGregor, PhD
Zeta
Potential 2 50
David Fairhurst, PhD
Robert W. Lee, PhD
FEATURING
The science & business of drug development in specialty pharma, biotechnology, and drug delivery
Outsourcing
Trends
Jennifer Brice
Barath Shankar
Development
Strategies
Andrew MacGarvey
64
Fethi Trabelsi,
PhD
Importance of
Phamacokinetic/
Pharmacodynamic
Studies During
Biosimilar Clinical
Development
Cindy Dubin
Biologics, Self-Administration &
Patient Adherence:
Creating a Lucrative
Hand-Held Injection
Market
Josef Bossart,
PhD
DDEP Sales &
Prescription
Performance 2010,
Hints of the Future
66
